214 related articles for article (PubMed ID: 29737218)
21. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
22. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
23. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
24. Australian consensus recommendations for the management of hepatitis B.
Lubel JS; Strasser SI; Thompson AJ; Cowie BC; MacLachlan J; Allard NL; Holmes J; Kemp WW; Majumdar A; Iser D; Howell J; Matthews GV
Med J Aust; 2022 May; 216(9):478-486. PubMed ID: 35249220
[TBL] [Abstract][Full Text] [Related]
25. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
Lao XM; Luo G; Ye LT; Luo C; Shi M; Wang D; Guo R; Chen M; Li S; Lin X; Yuan Y
Liver Int; 2013 Apr; 33(4):595-604. PubMed ID: 23402625
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus infection in children and adolescents.
Indolfi G; Easterbrook P; Dusheiko G; Siberry G; Chang MH; Thorne C; Bulterys M; Chan PL; El-Sayed MH; Giaquinto C; Jonas MM; Meyers T; Walsh N; Wirth S; Penazzato M
Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):466-476. PubMed ID: 30982722
[TBL] [Abstract][Full Text] [Related]
29. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study.
Minier N; Guingané AN; Okeke E; Sinkala E; Johannessen A; Andersson MI; Davwar P; Desalegn H; Duguru M; Fall F; Mboup S; Maponga T; Matthews PC; Ramírez Mena A; Ndow G; Orlien SMS; Riches N; Seydi M; Sonderup M; Spearman CW; Stockdale AJ; Taljaard J; Vinikoor M; Wandeler G; Lemoine M; Shimakawa Y; Sombié R
Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):323-332. PubMed ID: 38367633
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis B virus (HBV) infection in Sub-Saharan immigrants in Almería (Spain)].
Salas J; Vázquez J; Cabezas T; Lozano AB; Cabeza I
Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):121-3. PubMed ID: 21330010
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular Carcinoma in Sub-Saharan Africa.
Kedar Mukthinuthalapati VVP; Sewram V; Ndlovu N; Kimani S; Abdelaziz AO; Chiao EY; Abou-Alfa GK
JCO Glob Oncol; 2021 May; 7():756-766. PubMed ID: 34043413
[TBL] [Abstract][Full Text] [Related]
33. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
Iloeje UH; Yang HI; Chen CJ
Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
[TBL] [Abstract][Full Text] [Related]
34. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
36. New horizons in hepatitis B and C in the older adult.
Kemp L; Clare KE; Brennan PN; Dillon JF
Age Ageing; 2019 Jan; 48(1):32-37. PubMed ID: 30379991
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C and hepatocellular carcinoma.
Fassio E
Ann Hepatol; 2010; 9 Suppl():119-22. PubMed ID: 20714008
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
Park YM; Lee SG
World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
[TBL] [Abstract][Full Text] [Related]
39. Management of chronic hepatitis B in severe liver disease.
Fung J; Lai CL; Yuen MF
World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
[TBL] [Abstract][Full Text] [Related]
40. Management of patients with decompensated HBV cirrhosis.
Fontana RJ
Semin Liver Dis; 2003 Feb; 23(1):89-100. PubMed ID: 12616454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]